Related Experiment Video
Updated: Jul 8, 2026

12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Correlation between ocular pulse amplitude measured by dynamic contour tonometer and visual field defects
Chantal Vulsteke1, Ingeborg Stalmans, Steffen Fieuws
1Department of Ophthalmology, Middelheim Hospital Antwerp, Lindendreef 1, 2020, Antwerp, Belgium. chantalvulsteke@yahoo.com
Summary
A small ocular pulse amplitude (OPA) is linked to moderate to severe visual field loss in glaucoma patients. This finding suggests OPA may be a risk factor for developing glaucomatous visual field defects.
Area of Science:
- Ophthalmology
- Optometry
- Glaucoma Research
Background:
- Glaucoma is a leading cause of irreversible blindness worldwide.
- Visual field defects are a primary indicator of glaucoma progression.
- Ocular pulse amplitude (OPA) is a measure of intraocular pressure variation.
Purpose of the Study:
- To investigate the correlation between ocular pulse amplitude (OPA) and visual field defects in patients with glaucoma, ocular hypertension, and glaucoma suspicion.
- To determine if OPA is an independent predictor of visual field parameters using the Pascal Dynamic Contour Tonometer.
Main Methods:
- Seventy-seven eyes from 42 patients were analyzed.
- OPA was measured using the dynamic contour tonometer by a masked investigator.
- Visual fields were assessed within three months and analyzed for mean defect (MD) and pattern standard deviation (PSD).
Main Results:
- A significant correlation was found between OPA and MD and PSD, even after adjusting for intraocular pressure (IOP).
- A weak correlation was observed between OPA and the evolution of MD over time.
- This correlation weakened and became non-significant after correction for IOP, diagnostic group, and eye.
Conclusions:
- A small ocular pulse amplitude is correlated with moderate to severe glaucomatous visual field loss.
- Reduced OPA may serve as a potential risk factor for the development of glaucomatous visual field defects.

